Richard P. Bryce's most recent trade in enGene Holdings Inc was a trade of 153,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 30, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
enGene Holdings Inc | Richard P. Bryce | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 153,000 | 153,000 | - | - | Stock Option (Right to Buy) | |
Rain Oncology Inc | Richard P. Bryce | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
Rain Oncology Inc | Richard P. Bryce | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 53,064 | 53,064 | - | - | Stock Option (Right to Buy) | |
Puma Biotechnology Inc | Richard P. Bryce | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 9.80 per share. | 05 Apr 2021 | 426 | 121,662 (0%) | 0% | 9.8 | 4,176 | COMMON STOCK |
Puma Biotechnology Inc | Richard P. Bryce | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 10.15 per share. | 02 Mar 2021 | 422 | 122,088 (0%) | 0% | 10.1 | 4,283 | COMMON STOCK |
Puma Biotechnology Inc | Richard P. Bryce | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 74,341 | 74,341 | - | - | STOCK OPTION (RIGHT TO BUY) | |
Puma Biotechnology Inc | Richard P. Bryce | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 52,846 | 122,510 (0%) | 0% | 0 | COMMON STOCK | |
Puma Biotechnology Inc | Richard P. Bryce | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 12.23 per share. | 02 Feb 2021 | 415 | 69,664 (0%) | 0% | 12.2 | 5,076 | COMMON STOCK |
Puma Biotechnology Inc | Richard P. Bryce | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 10.23 per share. | 04 Jan 2021 | 6,548 | 70,079 (0%) | 0% | 10.2 | 67,016 | COMMON STOCK |
Puma Biotechnology Inc | Richard P. Bryce | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 11.65 per share. | 02 Dec 2020 | 92 | 76,627 (0%) | 0% | 11.7 | 1,072 | COMMON STOCK |
Puma Biotechnology Inc | Richard P. Bryce | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 02 Nov 2020 | 97 | 76,719 (0%) | 0% | 7.8 | 758 | COMMON STOCK |
Puma Biotechnology Inc | Richard P. Bryce | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 10.14 per share. | 02 Oct 2020 | 91 | 76,816 (0%) | 0% | 10.1 | 923 | COMMON STOCK |
Puma Biotechnology Inc | Richard P. Bryce | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 9.77 per share. | 02 Sep 2020 | 90 | 76,907 (0%) | 0% | 9.8 | 879 | COMMON STOCK |